Fuan Pharmaceutical Group Co Cash Flow Conversion Efficiency
Fuan Pharmaceutical Group Co cash flow conversion efficiency. Based on the latest financial reports, Fuan Pharmaceutical Group Co (300194) has a cash flow conversion efficiency ratio of 0.023x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥100.27 Million ≈ $14.67 Million USD) by net assets (CN¥4.45 Billion ≈ $651.79 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Fuan Pharmaceutical Group Co (2007–2025)
Cash flow conversion efficiency of Fuan Pharmaceutical Group Co from 2007 to 2025. This chart illustrates how Fuan Pharmaceutical Group Co's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Fuan Pharmaceutical Group Co for real-time trading data and today's change.
Fuan Pharmaceutical Group Co Cash Flow Conversion Ratio Explained
Fuan Pharmaceutical Group Co cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Fuan Pharmaceutical Group Co Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Fuan Pharmaceutical Group Co ranked by their cash flow conversion efficiency. Also see 300194 market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Qfin Holdings, Inc.
NASDAQ:QFIN
|
0.044x |
|
Ningxia Xinri Hengli Steel Wire Rope Co Ltd
SHG:600165
|
-0.040x |
|
Weikeng Industrial Co Ltd
TW:3033
|
-0.355x |
|
Zhejiang Zomax Transmission
SHG:603767
|
0.010x |
|
Zhejiang Chunhui Intelligent Control Co. Ltd.
SHE:300943
|
-0.001x |
|
Beijing Asiacom Information Technology Co.Ltd
SHE:301085
|
N/A |
|
Zee Entertainment Enterprises Limited
NSE:ZEEL
|
-0.002x |
|
Jenkem Technology Co Ltd
SHG:688356
|
-0.013x |
Annual Cash Flow Conversion Efficiency for Fuan Pharmaceutical Group Co (2007–2025)
The table below shows the annual cash flow conversion efficiency of Fuan Pharmaceutical Group Co from 2007 to 2025. Review Fuan Pharmaceutical Group Co free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥4.37 Billion ≈ $638.81 Million |
CN¥312.32 Million ≈ $45.70 Million |
0.072x | +3.65% |
| 2024-12-31 | CN¥4.40 Billion ≈ $643.58 Million |
CN¥303.59 Million ≈ $44.42 Million |
0.069x | -12.95% |
| 2023-12-31 | CN¥4.15 Billion ≈ $607.09 Million |
CN¥328.98 Million ≈ $48.14 Million |
0.079x | -7.82% |
| 2022-12-31 | CN¥3.95 Billion ≈ $577.49 Million |
CN¥339.50 Million ≈ $49.68 Million |
0.086x | +29.34% |
| 2021-12-31 | CN¥3.87 Billion ≈ $565.70 Million |
CN¥257.13 Million ≈ $37.63 Million |
0.067x | +86.38% |
| 2020-12-31 | CN¥4.56 Billion ≈ $666.55 Million |
CN¥162.55 Million ≈ $23.79 Million |
0.036x | -51.84% |
| 2019-12-31 | CN¥3.99 Billion ≈ $583.77 Million |
CN¥295.63 Million ≈ $43.26 Million |
0.074x | +2.27% |
| 2018-12-31 | CN¥3.69 Billion ≈ $540.55 Million |
CN¥267.68 Million ≈ $39.17 Million |
0.072x | -33.34% |
| 2017-12-31 | CN¥4.17 Billion ≈ $610.29 Million |
CN¥453.37 Million ≈ $66.34 Million |
0.109x | +15.16% |
| 2016-12-31 | CN¥3.96 Billion ≈ $580.00 Million |
CN¥374.16 Million ≈ $54.75 Million |
0.094x | +25.23% |
| 2015-12-31 | CN¥2.14 Billion ≈ $312.59 Million |
CN¥161.03 Million ≈ $23.56 Million |
0.075x | +511.64% |
| 2014-12-31 | CN¥1.71 Billion ≈ $249.86 Million |
CN¥-31.27 Million ≈ $-4.58 Million |
-0.018x | -135.25% |
| 2013-12-31 | CN¥1.72 Billion ≈ $252.41 Million |
CN¥89.61 Million ≈ $13.11 Million |
0.052x | +42.41% |
| 2012-12-31 | CN¥1.72 Billion ≈ $251.77 Million |
CN¥62.77 Million ≈ $9.18 Million |
0.036x | -4.80% |
| 2011-12-31 | CN¥1.69 Billion ≈ $247.66 Million |
CN¥64.85 Million ≈ $9.49 Million |
0.038x | -89.82% |
| 2010-12-31 | CN¥281.05 Million ≈ $41.13 Million |
CN¥105.74 Million ≈ $15.47 Million |
0.376x | -2.08% |
| 2009-12-31 | CN¥163.31 Million ≈ $23.90 Million |
CN¥62.75 Million ≈ $9.18 Million |
0.384x | -13.55% |
| 2008-12-31 | CN¥110.76 Million ≈ $16.21 Million |
CN¥49.23 Million ≈ $7.20 Million |
0.444x | -80.47% |
| 2007-12-31 | CN¥8.31 Million ≈ $1.22 Million |
CN¥18.92 Million ≈ $2.77 Million |
2.276x | -- |
About Fuan Pharmaceutical Group Co
Fuan Pharmaceutical (Group) Co., Ltd., together with its subsidiaries, research and develops, produces, and sells chemical drugs in the People's Republic of China and internationally. It offers APIs; intermediates; and FDFs, such as anti-tumor, specialty drugs, antibiotics, as well as freeze-drying preparation for injection. The company was formerly known as Chongqing Fuan Pharmaceutical (Group) … Read more